562
Views
21
CrossRef citations to date
0
Altmetric
Original Articles

Coffee, Green Tea, and Caffeine Intake and Liver Cancer Risk: A Prospective Cohort Study

ORCID Icon, , , , , , , , , & show all
Pages 1210-1216 | Received 20 Sep 2017, Accepted 03 Aug 2018, Published online: 20 Nov 2018

References

  • McGlynn KA, Petrick JL, and London WT: Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis 19, 223–238, 2015.
  • Parkin DM: The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118, 3030–3044, 2006.
  • World Cancer Research Fund/American Institute for Cancer Research: Food, nutrition, physical activity, and the prevention of cancer: global perspective. Washington DC: American Institute for Cancer Research, 2007.
  • Saab S, Mallam D, Cox GA 2nd, and Tong MJ: Impact of coffee on liver diseases: a systematic review. Liver Int 34, 495–504, 2014.
  • Yuan JM: Cancer prevention by green tea: evidence from epidemiologic studies. Am J Clin Nutr 98, 1676S–1681S, 2013.
  • Loomis D, Guyton KZ, Grosse Y, Lauby-Secretan B, El Ghissassi F, et al.: Carcinogenicity of drinking coffee, mate, and very hot beverages. Lancet Oncol 17, 877–878, 2016.
  • Graham HN: Green tea composition, consumption, and polyphenol chemistry. Prev Med 21, 334–350, 1992.
  • Yang CS, Ju J, Lu G, Xiao H, Hao X, et al.: Cancer prevention by tea and tea polyphenols. Asia Pac J Clin Nutr 17, 245–248, 2008.
  • Nkondjock A: Coffee consumption and the risk of cancer: an overview. Cancer Lett 277, 121–125, 2009.
  • Yu C, Cao Q, Chen P, Yang S, Deng M, et al.: An updated dose-response meta-analysis of coffee consumption and liver cancer risk. Sci Rep 6, 37488, 2016.
  • Ni CX, Gong H, Liu Y, Qi Y, Jiang CL, et al.: Green Tea Consumption and the Risk of Liver Cancer: A Meta-Analysis. Nutr Cancer 69, 211–220, 2017.
  • Shimazu T, Tsubono Y, Kuriyama S, Ohmori K, Koizumi Y, et al.: Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int J Cancer 116, 150–154, 2005.
  • Kurozawa Y, Ogimoto I, Shibata A, Nose T, Yoshimura T, et al.: Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer 93, 607–610, 2005.
  • Ohishi W, Fujiwara S, Cologne JB, Suzuki G, Akahoshi M, et al.: Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol Biomarkers Prev 17, 846–854, 2008.
  • Inoue M, Kurahashi N, Iwasaki M, Shimazu T, Tanaka Y, et al.: Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. Cancer Epidemiol Biomarkers Prev 18, 1746–1753, 2009.
  • Johnson S, Koh WP, Wang R, Govindarajan S, Yu MC, et al.: Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study. Cancer Causes Control 22, 503–510, 2011.
  • Lai GY, Weinstein SJ, Albanes D, Taylor PR, McGlynn KA, et al.: The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers. Br J Cancer 109, 1344–1351, 2013.
  • Bamia C, Lagiou P, Jenab M, Trichopoulou A, Fedirko V, et al.: Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: multicentre, prospective cohort study. Int J Cancer 136, 1899–1908, 2015.
  • Petrick JL, Freedman ND, Graubard BI, Sahasrabuddhe VV, Lai GY, et al.: Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project. Cancer Epidemiol Biomarkers Prev 24, 1398–1406, 2015.
  • Setiawan VW, Wilkens LR, Lu SC, Hernandez BY, Le Marchand L, et al.: Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort. Gastroenterology 148, 118–125, 2015.
  • Ui A, Kuriyama S, Kakizaki M, Sone T, Nakaya N, et al.: Green tea consumption and the risk of liver cancer in Japan: the Ohsaki Cohort study. Cancer Causes Control 20, 1939–1945, 2009.
  • Nagano J, Kono S, Preston DL, and Mabuchi K: A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan). Cancer Causes Control 12, 501–508, 2001.
  • Wang N, Zheng Y, Jiang Q, Yu X, and Chen Y: Tea and reduced liver cancer mortality. Epidemiology 19, 761, 2008.
  • Nechuta S, Shu XO, Li HL, Yang G, Ji BT, et al.: Prospective cohort study of tea consumption and risk of digestive system cancers: results from the Shanghai Women's Health Study. Am J Clin Nutr 96, 1056–1063, 2012.
  • Shimizu H: The basic report on Takayama study. Gifu: Department of Public Health, Gifu University School of Medicine, 1996.
  • Nagata C, Kabuto M, Takatsuka N, and Shimizu H: Associations of alcohol, height, and reproductive factors with serum hormone concentrations in postmenopausal Japanese women. Steroid hormones in Japanese postmenopausal women. Breast Cancer Res Treat 44, 235–241, 1997.
  • Ministry of Education, Culture, Sports, Science and Technology, Japan: Standard Tables of Food Composition in Japan, Fifth revised and enlarged edition. Tokyo: National Printing Bureau, 2005.
  • Barone JJ and Roberts HR: Caffeine consumption. Food Chem Toxicol 34, 119–129, 1996.
  • Shimizu H, Ohwaki A, Kurisu Y, Takatsuka N, Ido M, et al.: Validity and reproducibility of a quantitative food frequency questionnaire for a cohort study in Japan. Jpn J Clin Oncol 29, 38–44, 1999.
  • Suzuki I, Kawakami N, and Shimizu H: Reliability and validity of a questionnaire for assessment of energy expenditure and physical activity in epidemiological studies. J Epidemiol 8, 152–159, 1998.
  • Willett W: Implication of total energy intake for epidemiological analyses. Nutritional Epidemiology, Willett W ed., New York: Oxford University Press, 1990, pp 245–271.
  • Bohn SK, Blomhoff R, and Paur I: Coffee and cancer risk, epidemiological evidence and molecular mechanisms. Mol Nutr Food Res 58, 915–930, 2014.
  • Nishikawa T, Nakajima T, Moriguchi M, Jo M, Sekoguchi S, et al.: A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. J Hepatol 44, 1074–1082, 2006.
  • Schmidt M, Schmitz HJ, Baumgart A, Guédon D, Netsch MI, et al.: Toxicity of green tea extracts and their constituents in rat hepatocytes in primary culture. Food Chem Toxicol 43, 307–314, 2005.
  • Suh KS, Chon S, Oh S, Kim SW, Kim JW, et al.: Prooxidative effects of green tea polyphenol (-)-epigallocatechin-3-gallate on the HIT-T15 pancreatic beta cell line. Cell Biol Toxicol 26, 189–199, 2010.
  • Gloro R, Hourmand-Ollivier I, Mosquet B, Mosquet L, Rousselot P, et al.: Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea. Eur J Gastroenterol Hepatol 17, 1135–1137, 2005.
  • Richelle M, Tavazzi I, and Offord E: Comparison of the antioxidant activity of commonly consumed polyphenolic beverages (coffee, cocoa, and tea) prepared per cup serving. J Agric Food Chem 49, 3438–3442, 2001

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.